The determination of the vasoactivity of mepivacaine and its isomers
Jeske, A.H.; Gangarosa, L.P.
Methods and Findings in Experimental and Clinical Pharmacology 3(1): 33-39
1981
ISSN/ISBN: 0379-0355 PMID: 7230974 Document Number: 181481
Document emailed within 1 workday
Related Documents
Breuer, H. 1982: Gas-liquid chromatographic determination of lidocaine in cat plasma using mepivacaine as internal standard Journal of Chromatography 231(1): 65-72Rzeszutko, W. 1974: New method for the determination of aminophenol isomers in their mixtures Acta Poloniae Pharmaceutica 31(3): 323-329
Rushin, W.G.; Catignani, G.L.; Schwartz, S.J. 1990: Determination of beta-carotene and its cis isomers in serum Clinical Chemistry 36(11): 1986-1989
Taeger, L.; Wagner, F. 1988: Combined ischiatic/3-in-1-block. II. 1 percent mepivacaine HCl versus 1 percent CO2 mepivacaine Regional-Anaesthesie 11(2): 50-53
Morvay, J.; Péter, S. 1972: Disturbing effect of N-dimethylamino acetylphenothiazide in layer chromatographic determination of pregnanediol isomers Acta Pharmaceutica Hungarica 42(2): 92-96
Bogomolova, Z.N.; Tarasova, A.M. 1973: Separate determination of HCCH and phenothiazine isomers when present together in products of animal origin Voprosy Pitaniia 32(4): 72-74
Zhu, W.; Wu, F.; Huang, T. 2008: Determination of kinetic transformation of two geometrical isomers of the [Fe(PDT)3]2+ by high performance liquid chromatography Se Pu 26(5): 550-553
Rui, L.; Xu, X.; Li, Y.; Song, G.; Han, J.; Ren, Y. 2010: Determination of trans fatty acid C18:1, C18:2 and C18:3 isomers in milk fat by silver ion solid phase extraction-gas chromatography Se Pu 28(12): 1168-1172
Gurwitz, D. 1996: Beta-Amyloid vasoactivity in Alzheimer's disease Lancet 347(9013): 1492
Escalante, B.; Sessa, W.C.; Falck, J.R.; Yadagiri, P.; Schwartzman, M.L. 1989: Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase Journal of Pharmacology and Experimental Therapeutics 248(1): 229-232
Yashon, D.; Blocker, D.; Brown, R.J.; Hunt, W.E. 1975: Quantitative in vitro vasoactivity of 5-hydroxytryptamine on the human basilar artery Surgical Neurology 3(6): 295-300
Immink, W.F.; Ouwejan, G.H.; Charbon, G.A. 1984: Vasoactivity of adrenaline in regions covering the canine gastrointestinal tract Archives Internationales de Pharmacodynamie et de Therapie 268(1): 75-87
McEnany, M.T.; Morgan, R.J.; Mundth, E.D.; Austen, W.G. 1975: Circumvention of detrimental pulmonary vasoactivity of exogenous catecholamines in cardian resuscitation Surgical Forum 26: 98-101
Hiyoshi, K.; Iwanaga, Y.; Kado, K.; Takeda, K. 1978: Allergic reactions caused by mepivacaine Masui. Japanese Journal of Anesthesiology 27(2): 177-180
Trevilla Guerrero, J.A.; Domínguez Gómez, A.; Herrero Gracia, M.A. 1981: Regional intravenous anesthesia of the upper limb with mepivacaine Revista Espanola de Anestesiologia y Reanimacion 28(1): 3-5
Wagner, F.; Taeger, L. 1988: Combined sciatic/3-in-1 block. III. Prilocaine 1% versus mepivacaine 1% Regional-Anaesthesie 11(3): 61-64
Büttner, J.; Klose, R. 1991: Alkalinization of mepivacaine for axillary plexus anesthesia using a catheter Regional-Anaesthesie 14(1): 17-24
Smith, R.F.; Wharton, G.G.; Kurtz, S.L.; Mattran, K.M.; Hollenbeck, A.R. 1986: Behavioral effects of mid-pregnancy administration of lidocaine and mepivacaine in the rat Neurobehavioral Toxicology and Teratology 8(1): 61-68
Eckstein, K.L.; Rogacev, Z.; Grahovac, Z.; Vicente-Eckstein, A. 1983: Peak blood levels of mepivacaine following intravenous regional anesthesia using various concentrations Regional-Anaesthesie 6(2): 23-26
Ding, S.; Zhu, Y.-Q.; Wu, Y.-N.; Cao, D. 2008: Efficacy and safety of 3% mepivacaine hydrochloride injection for oral local anesthesia Shanghai Kou Qiang Yi Xue 17(3): 328-331